Gregory S. Calip

3.3k total citations
175 papers, 2.1k citations indexed

About

Gregory S. Calip is a scholar working on Oncology, Hematology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Gregory S. Calip has authored 175 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Oncology, 49 papers in Hematology and 43 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Gregory S. Calip's work include Multiple Myeloma Research and Treatments (29 papers), Global Cancer Incidence and Screening (25 papers) and Economic and Financial Impacts of Cancer (21 papers). Gregory S. Calip is often cited by papers focused on Multiple Myeloma Research and Treatments (29 papers), Global Cancer Incidence and Screening (25 papers) and Economic and Financial Impacts of Cancer (21 papers). Gregory S. Calip collaborates with scholars based in United States, China and United Kingdom. Gregory S. Calip's co-authors include Naomi Y. Ko, Denise M. Boudreau, Todd A. Lee, Katie J. Suda, Jifang Zhou, Kent Hoskins, Glen T. Schumock, Susan Rowan, Judith A. Malmgren and Henry G. Kaplan and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Gregory S. Calip

164 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gregory S. Calip United States 24 632 445 273 258 248 175 2.1k
Amy Cantor United States 24 648 1.0× 336 0.8× 271 1.0× 155 0.6× 109 0.4× 57 2.2k
Ted Wun United States 28 392 0.6× 591 1.3× 185 0.7× 684 2.7× 225 0.9× 75 2.9k
Rahul Mhaskar United States 23 693 1.1× 225 0.5× 332 1.2× 374 1.4× 198 0.8× 150 2.0k
Sue Ward United Kingdom 25 522 0.8× 277 0.6× 165 0.6× 160 0.6× 109 0.4× 70 2.3k
John Hornberger United States 21 282 0.4× 211 0.5× 281 1.0× 172 0.7× 143 0.6× 42 2.8k
Peter C. Raich United States 26 1.5k 2.4× 629 1.4× 292 1.1× 194 0.8× 155 0.6× 56 2.7k
Mark Tacey Australia 24 468 0.7× 214 0.5× 403 1.5× 91 0.4× 166 0.7× 159 2.9k
Thomas E. Delea United States 26 763 1.2× 133 0.3× 131 0.5× 425 1.6× 298 1.2× 136 2.4k
Patrik Finne Finland 39 482 0.8× 305 0.7× 346 1.3× 170 0.7× 678 2.7× 131 3.8k
Marialena Trivella United Kingdom 35 394 0.6× 287 0.6× 391 1.4× 740 2.9× 271 1.1× 111 4.0k

Countries citing papers authored by Gregory S. Calip

Since Specialization
Citations

This map shows the geographic impact of Gregory S. Calip's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory S. Calip with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory S. Calip more than expected).

Fields of papers citing papers by Gregory S. Calip

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory S. Calip. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory S. Calip. The network helps show where Gregory S. Calip may publish in the future.

Co-authorship network of co-authors of Gregory S. Calip

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory S. Calip. A scholar is included among the top collaborators of Gregory S. Calip based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory S. Calip. Gregory S. Calip is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ramanathan, Swetha, Charlesnika T. Evans, Ronald C. Hershow, et al.. (2024). Guideline concordance and antibiotic-associated adverse events between Veterans administration and non-Veterans administration dental settings: a retrospective cohort study. Frontiers in Pharmacology. 15. 1249531–1249531. 1 indexed citations
2.
Guadamuz, Jenny S., Xiaoliang Wang, Ivy Altomare, et al.. (2024). Mediators of racial and ethnic inequities in clinical trial participation among patients with cancer, 2011-2023. JNCI Cancer Spectrum. 8(5).
3.
Miksad, Rebecca A. & Gregory S. Calip. (2024). Future of Cancer Treatment Guidelines: Integrating Real-World Insights for Equitable Cancer Care. JCO Clinical Cancer Informatics. 8(8). e2400081–e2400081. 1 indexed citations
4.
Canavan, Maureen, Xiaoliang Wang, Mustafa Ascha, et al.. (2024). Systemic Anticancer Therapy and Overall Survival in Patients With Very Advanced Solid Tumors. JAMA Oncology. 10(7). 887–887. 12 indexed citations
5.
Mohyuddin, Ghulam Rehman, Jenny S. Guadamuz, Mustafa Ascha, et al.. (2024). Comparison of patients with myeloma receiving zoledronic acid vs denosumab: a nationwide retrospective cohort study. Blood Advances. 8(21). 5539–5541. 2 indexed citations
6.
Holt, Hunter K., et al.. (2023). Mediation of Racial and Ethnic Inequities in the Diagnosis of Advanced-Stage Cervical Cancer by Insurance Status. JAMA Network Open. 6(3). e232985–e232985. 28 indexed citations
7.
Howard, Rachel, et al.. (2023). Assessing the Contribution of Scanned Outside Documents to the Completeness of Real-World Data Abstraction. JCO Clinical Cancer Informatics. 7(7). e2200118–e2200118. 3 indexed citations
8.
Ramanathan, Swetha, Colin C. Hubbard, Gregory S. Calip, et al.. (2023). Changes in antibiotic prescribing by dentists in the United States, 2012–2019. Infection Control and Hospital Epidemiology. 44(11). 1725–1730. 11 indexed citations
9.
Guadamuz, Jenny S., Xiaoliang Wang, Rebecca A. Miksad, et al.. (2023). Socioeconomic status and inequities in treatment initiation and survival among patients with cancer, 2011-2022. JNCI Cancer Spectrum. 7(5). 27 indexed citations
10.
11.
Zhou, Jifang, Gregory S. Calip, Edith A. Nutescu, et al.. (2021). Type 2 diabetes mellitus burdens among adults with sickle cell disease: A 12‐year single health system‐based cohort analysis. SHILAP Revista de lepidopterología. 2(1). 94–98. 2 indexed citations
12.
Zhou, Jifang, Karen Sweiss, Edith A. Nutescu, et al.. (2021). Racial Disparities in Intravenous Bisphosphonate Use Among Older Patients With Multiple Myeloma Enrolled in Medicare. JCO Oncology Practice. 17(3). e294–e312. 9 indexed citations
13.
14.
Lee, In-Young, et al.. (2020). Exploring Completeness of Adverse Event Reports as a Tool for Signal Detection in Pharmacovigilance. Therapeutic Innovation & Regulatory Science. 55(1). 142–151. 3 indexed citations
15.
16.
Zhou, Jifang, Jin Han, Edith A. Nutescu, et al.. (2019). Similar burden of type 2 diabetes among adult patients with sickle cell disease relative to African Americans in the U.S. population: a six‐year population‐based cohort analysis. British Journal of Haematology. 185(1). 116–127. 12 indexed citations
17.
Zhou, Jifang, Jin Han, Edith A. Nutescu, et al.. (2018). Hydroxycarbamide adherence and cumulative dose associated with hospital readmission in sickle cell disease: a 6‐year population‐based cohort study. British Journal of Haematology. 182(2). 259–270. 13 indexed citations
18.
Han, Jin, Jifang Zhou, Santosh L. Saraf, Victor R. Gordeuk, & Gregory S. Calip. (2017). Characterization of opioid use in sickle cell disease. Pharmacoepidemiology and Drug Safety. 27(5). 479–486. 41 indexed citations
19.
Zhou, Jifang, Gregory S. Calip, Jin Han, & Edith A. Nutescu. (2017). Impact of Delayed Anticoagulant Initiation in Patients with Sickle Cell Disease and Newly Diagnosed Venous Thromboembolism: A Population-Based Cohort Study. Blood. 130. 2139–2139. 1 indexed citations
20.
Calip, Gregory S., et al.. (2013). Impact of the Family Health Program on gastroenteritis in children in Bahia, Northeast Brazil: An analysis of primary care-sensitive conditions. SHILAP Revista de lepidopterología. 3(3). 175–175. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amy Cantor Breakdown of academic impact, for papers by Ted Wun Breakdown of academic impact, for papers by Rahul Mhaskar Breakdown of academic impact, for papers by Sue Ward Breakdown of academic impact, for papers by John Hornberger Breakdown of academic impact, for papers by Peter C. Raich Breakdown of academic impact, for papers by Mark Tacey Breakdown of academic impact, for papers by Thomas E. Delea Breakdown of academic impact, for papers by Patrik Finne Breakdown of academic impact, for papers by Marialena Trivella
Rankless by CCL
2026